• MeiraGTx appointed John Knighton executive vice president of global manufacturing and supply chain in July 2026.
• Knighton previously served as vice president, cell and gene therapy API development, at Janssen Pharmaceuticals.
• Alan M. Sebulsky joined the board of directors in September 2026.
• Sebulsky most recently spent 14 years as partner and portfolio manager at Adage Capital Management.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611120800PRIMZONEFULLFEED9876112) on November 12, 2026, and is solely responsible for the information contained therein.